Search results
ACC 2026 Late-Breaking Science Collection
Video Series
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
TCT 2024 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.Dive into this practical and engaging discussion and learn more about the latest data for practice and for research.Trials covered in…
View more
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
1 year ago
Dive into our collection covering the hot line and late-breaking trials presented at EuroPCR 2025. Reviewing the sessions you don't want to miss, interventional experts Prof Nicolas Van MieghemandDr Joost Daemen will be leading our regular series View From the Thoraxcenter. For a deeper dive into the most anticipated trials, our Expert Interviews have you covered.
View more
Added:
10 months ago
Source:
ESC Congress 2025 Scientific Programme
ESC Congress 2025 has released twenty-eight late-breaking trials and science sessions to be presented in August 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Late-Breaking Clinical Science: Inflammation and Immune Biomarkers in Cardiovascular Risk PredictionFriday 29th August, 08:15am – 09:45am (CEST…
View more
Author(s):
Deepak L Bhatt
Added:
1 month ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO…
View more
Author(s):
Babar Basir
,
Karim Al-Azizi
Added:
1 month ago
ACC 2026 — Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, front-line interventional view of the STEMI Door-to-Unload (STEMI-DTU) trial (NCT03000270), making this an efficient 5-minute update for cardiologists and cath lab teams.STEMI-DTU randomised haemodynamically stable patients aged 18–85 years with a first acute…
View more
TCT 2025 Late-Breaking Science Collection
Video Series
AF Symposium 2026 Late-Breaking Science Collection
Video Series
Author(s):
Nicolas M Van Mieghem
Added:
6 months ago
Stay at the forefront of cardiovascular medicine with our comprehensive video collection from the American Heart Association's Scientific Sessions 2025. Access expert analysis of the most impactful late-breaking trials and featured science shaping clinical practice.Late-Breaker Discussions: Watch Dr Harriette Van Spall break down pivotal clinical trial data and explore its implications for…
View more
Author(s):
Harriette Van Spall
,
Luke Laffin
Added:
1 year ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial…
View more